In an additional, 30-week placebo-controlled, study of patients with type 2 diabetes inadequately controlled with metformin comparing the maintenance of sitagliptin 100 mg versus withdrawal of sitagliptin when initiating basal insulin therapy, the event rate and incidence of documented symptomatic hypoglycemia (blood glucose measurement 70 mg/dL) did not differ between the sitagliptin and placebo groups
The muscle preservation protocol for men on tirzepatide Losing fat is the goal
Rationale: Semaglutide reduces appetite and caloric intake while Lipo-C enhances fat metabolism and energy production
The answers below cover the topics that come up most often for healthfocused professionals and biohackers
Particularly where disagreements arise and, in the absence of comprehensive guidance for care providers, the courts may be called upon to resolve these difficult issues
The question is: how do we optimize ECS-targeting therapies to treat seizures, pain, neuroprotection, and appetite dysregulation across indications